The world urgently needs 20 billion doses of a vaccine that will protect global citizens against the coronavirus. States are throwing huge sums of public money at the race to beat Covid-19, but who will get there first? Will Big Pharma focus on private profit? Will vaccine nationalism prevail, or will the patent be shared to create a low-cost global supply?
May 2020
Público, Portugal
17 May 2020
Il Fatto Quotidiano, Italy
18 May 2020
Falter, Austria
20 May 2020
Republik, Switzerland
21 May 2020
Der Tagesspiegel, Germany
21 May 2020
Newsweek Poland, Poland
28 May 2020
Basta!, France, Basta!
22 July 2020
NRK, Norway
28 August 2020
NRK, Norway
28 August 2020
Stavanger Aftenblad, Norway
10 March 2021
Baricada Bulgaria, Bulgaria
19 March 2021
Baricada Bulgaria, Bulgaria
24 March 2021
Gazeta Wyborcza, Poland
10 May 2021
Público, Portugal
10 May 2021
EfSyn, Greece
10 May 2021
EUobserver, Belgium
23 September 2021
Klassekampen, Norway
23 September 2021
Il Fatto Quotidiano, Italy
23 September 2021
Público, Portugal
23 September 2021
Der Tagesspiegel, Germany
24 September 2021
EUobserver, Belgium
4 November 2021
taz, Germany
4 November 2021
Il Fatto Quotidiano, Italy
6 November 2022
Público, Portugal
8 November 2021
EfSyn, Greece
5 April 2022